To the Editor We read the article by Burgio et al1 on the effectiveness of combined behavioral and drug therapy for overactive bladder (OAB) symptoms in men with interest. The authors aimed to examine whether combining behavioral and drug therapies improves outcomes compared with each therapy alone. The participants were randomized to 6 weeks of behavioral training alone, drug therapy (antimuscarinic plus α-blocker) alone, or combined behavioral and drug therapy. After 6 weeks, participants receiving monotherapy were stepped up to combined (behavioral plus drug therapy) for an additional 6 weeks. At 6 weeks, posttreatment mean voiding frequencies (MVF) were lower in those receiving combined therapy than drug therapy alone but were not lower than posttreatment MVF in those receiving behavioral therapy alone. Also, MVF were lower for behavioral therapy alone than for drug therapy alone. At the 12th week, improvements in MVF were also greatest for the initial combined therapy group.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Bahat G, Gunaydin S, Karan MA. Considering the Effect of Combining α-Blockers With Bladder Antimuscarinics in Treatment of Overactive Bladder Symptoms. JAMA Intern Med. Published online May 11, 2020. doi:10.1001/jamainternmed.2020.1250
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: